rs141010716

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001256789.3(CACNA1F):​c.1870G>A​(p.Val624Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00316 in 1,160,649 control chromosomes in the GnomAD database, including 8 homozygotes. There are 1,109 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., 63 hem., cov: 21)
Exomes 𝑓: 0.0033 ( 8 hom. 1046 hem. )

Consequence

CACNA1F
NM_001256789.3 missense

Scores

1
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 0.448
Variant links:
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011872292).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00227 (252/110916) while in subpopulation NFE AF= 0.00405 (214/52878). AF 95% confidence interval is 0.0036. There are 0 homozygotes in gnomad4. There are 63 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 63 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1FNM_001256789.3 linkuse as main transcriptc.1870G>A p.Val624Ile missense_variant 14/48 ENST00000323022.10 NP_001243718.1 O60840-2
CACNA1FNM_005183.4 linkuse as main transcriptc.1903G>A p.Val635Ile missense_variant 14/48 NP_005174.2 O60840-1
CACNA1FNM_001256790.3 linkuse as main transcriptc.1708G>A p.Val570Ile missense_variant 14/48 NP_001243719.1 O60840-4
CACNA1FXM_011543983.3 linkuse as main transcriptc.1708G>A p.Val570Ile missense_variant 14/47 XP_011542285.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1FENST00000323022.10 linkuse as main transcriptc.1870G>A p.Val624Ile missense_variant 14/481 NM_001256789.3 ENSP00000321618.6 O60840-2
CACNA1FENST00000376265.2 linkuse as main transcriptc.1903G>A p.Val635Ile missense_variant 14/481 ENSP00000365441.2 O60840-1
CACNA1FENST00000376251.5 linkuse as main transcriptc.1708G>A p.Val570Ile missense_variant 14/481 ENSP00000365427.1 O60840-4

Frequencies

GnomAD3 genomes
AF:
0.00227
AC:
252
AN:
110862
Hom.:
0
Cov.:
21
AF XY:
0.00190
AC XY:
63
AN XY:
33088
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000763
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000387
Gnomad FIN
AF:
0.000336
Gnomad MID
AF:
0.00837
Gnomad NFE
AF:
0.00405
Gnomad OTH
AF:
0.00201
GnomAD3 exomes
AF:
0.00206
AC:
265
AN:
128537
Hom.:
0
AF XY:
0.00199
AC XY:
83
AN XY:
41733
show subpopulations
Gnomad AFR exome
AF:
0.000709
Gnomad AMR exome
AF:
0.000999
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000204
Gnomad FIN exome
AF:
0.000641
Gnomad NFE exome
AF:
0.00416
Gnomad OTH exome
AF:
0.00280
GnomAD4 exome
AF:
0.00326
AC:
3421
AN:
1049733
Hom.:
8
Cov.:
28
AF XY:
0.00313
AC XY:
1046
AN XY:
334273
show subpopulations
Gnomad4 AFR exome
AF:
0.000679
Gnomad4 AMR exome
AF:
0.000817
Gnomad4 ASJ exome
AF:
0.000214
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000179
Gnomad4 FIN exome
AF:
0.00117
Gnomad4 NFE exome
AF:
0.00389
Gnomad4 OTH exome
AF:
0.00320
GnomAD4 genome
AF:
0.00227
AC:
252
AN:
110916
Hom.:
0
Cov.:
21
AF XY:
0.00190
AC XY:
63
AN XY:
33152
show subpopulations
Gnomad4 AFR
AF:
0.000722
Gnomad4 AMR
AF:
0.000762
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000389
Gnomad4 FIN
AF:
0.000336
Gnomad4 NFE
AF:
0.00405
Gnomad4 OTH
AF:
0.00199
Alfa
AF:
0.00346
Hom.:
24
Bravo
AF:
0.00202
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00450
AC:
13
ESP6500AA
AF:
0.00105
AC:
4
ESP6500EA
AF:
0.00329
AC:
22
ExAC
AF:
0.00169
AC:
193

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Variant has been reported in unknown number of patients with XL congenital stationary night blindness (Weleber 2002 - from abstract, full text not available). MAF 0.6%, 6 hem in ExAC. Status PASS, but relatively poorly covered (51/9104 Eur chr). -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
not provided Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 29, 2016- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Congenital stationary night blindness 2A Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -
Retinal dystrophy Benign:1
Likely benign, criteria provided, single submitterclinical testingInstitute of Human Genetics, Univ. Regensburg, Univ. RegensburgJan 01, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
19
DANN
Benign
0.65
DEOGEN2
Uncertain
0.48
.;.;T
FATHMM_MKL
Benign
0.73
D
LIST_S2
Uncertain
0.86
D;D;D
M_CAP
Pathogenic
0.45
D
MetaRNN
Benign
0.012
T;T;T
MetaSVM
Uncertain
0.48
D
MutationAssessor
Uncertain
2.0
.;.;M
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.28
N;N;N
REVEL
Uncertain
0.39
Sift
Benign
0.55
T;T;T
Sift4G
Benign
0.38
T;T;T
Polyphen
0.66
.;.;P
Vest4
0.44
MVP
0.82
MPC
0.48
ClinPred
0.021
T
GERP RS
3.4
Varity_R
0.15
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141010716; hg19: chrX-49081230; API